Peer-influenced content. Sources you trust. No registration required. This is HCN.

Journal of Clinical OncologyClinical Outcomes of Molecular Tumor Boards: A Systematic Review

In this systematic review to evaluate the clinical outcomes associated with molecular tumor board (MTB) review in patients with cancer, 14 studies were included with a total of 3,328 patients. As the number of targetable mutations continues to increase and cancer care becomes even more complex, consultation with an interdisciplinary MTB can help guide therapy selection for patients with cancer.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form